Molindone hydrochloride

Molindone hydrochloride (CAS No.: 15622-65-8) is a synthetic small molecule neuropharmacology research compound, commonly classified as a first generation antipsychotic scaffold and functionally characterized as a dopamine receptor antagonist with primary activity at D2 like signaling, including reported D2 and D5 receptor blockade, making it a relevant tool for investigating dopaminergic neurotransmission, receptor level pharmacology, and circuit level modulation in central nervous system biology; as a brain penetrant agent in preclinical contexts, it is widely used to probe dopamine dependent behavioral and cellular phenotypes, including locomotor regulation, emesis related dopaminergic responses in animal systems, and mechanistic studies of receptor mediated signal transduction pathways linked to Gi and cyclic AMP associated downstream effects, with reported in vitro pharmacological potency generally described in the nanomolar to micromolar range depending on assay format, receptor subtype, species background, and readout platform, while broader off target interaction profiles and functional selectivity are typically addressed through multiparametric receptor screening panels; in biomedical research and drug discovery workflows, it is applied in cell based receptor antagonism assays, neurochemical pathway interrogation, comparative profiling against other dopaminergic ligands, and in vivo pharmacology models designed to evaluate central dopaminergic tone and behavioral endpoints, where the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, and overall its primary research category is central nervous system disease biology and mechanism driven small molecule screening rather than any non research use.